Literature DB >> 19639270

Procalcitonin and acute coronary syndromes: a new biomarker for an old disease.

Luigi M Biasucci1, Gina Biasillo, Antonella Stefanelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19639270     DOI： 10.1007/s11739-009-0295-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  16 in total

1.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

Authors:  B Lindahl; H Toss; A Siegbahn; P Venge; L Wallentin
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

2.  Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction.

Authors:  T Buratti; G Ricevuti; C Pechlaner; M Joannidis; F J Wiedermann; D Gritti; M Herold; C J Wiedermann
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

3.  Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.

Authors:  B Müller; K L Becker; H Schächinger; P R Rickenbacher; P R Huber; W Zimmerli; R Ritz
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

4.  Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro.

Authors:  M Oberhoffer; I Stonans; S Russwurm; E Stonane; H Vogelsang; U Junker; L Jäger; K Reinhart
Journal:  J Lab Clin Med       Date:  1999-07

5.  Procalcitonin in patients with acute myocardial infarction.

Authors:  Mojca Remskar; Matija Horvat; Sergej Hojker; Marko Noc
Journal:  Wien Klin Wochenschr       Date:  2002-03-28       Impact factor: 1.704

6.  Procalcitonin in acute myocardial infarction.

Authors:  Nikolaos Kafkas; Kiriaki Venetsanou; Sotirios Patsilinakos; Vasilios Voudris; Dionisios Antonatos; Kostas Kelesidis; George Baltopoulos; Peter Maniatis; Dennis V Cokkinos
Journal:  Acute Card Care       Date:  2008

7.  Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease.

Authors:  Tunay Sentürk; Jale Cordan; Ibrahim Baran; Bülent Ozdemir; Sümeyye Güllülü; Ali Aydinlar; Güher Göral
Journal:  Acta Cardiol       Date:  2007-04       Impact factor: 1.718

8.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

9.  Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention.

Authors:  Claudio Picariello; Chiara Lazzeri; Marco Chiostri; Gianfranco Gensini; Serafina Valente
Journal:  Intern Emerg Med       Date:  2009-07-08       Impact factor: 3.397

10.  The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.

Authors:  Jens-Ulrik Jensen; Bettina Lundgren; Lars Hein; Thomas Mohr; Pernille L Petersen; Lasse H Andersen; Anne O Lauritsen; Sine Hougaard; Teit Mantoni; Bonnie Bømler; Klaus J Thornberg; Katrin Thormar; Jesper Løken; Morten Steensen; Peder Carl; J Asger Petersen; Hamid Tousi; Peter Søe-Jensen; Morten Bestle; Søren Hestad; Mads H Andersen; Paul Fjeldborg; Kim M Larsen; Charlotte Rossau; Carsten B Thomsen; Christian Ostergaard; Jesper Kjaer; Jesper Grarup; Jens D Lundgren
Journal:  BMC Infect Dis       Date:  2008-07-13       Impact factor: 3.090
View more
  3 in total

Review 1.  Procalcitonin in acute cardiac patients.

Authors:  Claudio Picariello; Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-29       Impact factor: 3.397

2.  Differential inhibitory effect of fondaparinux on the procoagulant potential of intact monocytes and monocyte-derived microparticles.

Authors:  Sonia Ben-Hadj-Khalifa-Kechiche; Nathalie Hezard; Stephane Poitevin; Marie-Geneviève Remy; Bernadette Florent; Touhami Mahjoub; Philippe Nguyen
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

3.  Do MCHC, MPV, and Procalcitonin Levels Determine Prognosis in Acute Coronary Syndrome?

Authors:  Serhat Karaman; Abuzer Coskun
Journal:  Emerg Med Int       Date:  2019-07-18       Impact factor: 1.112
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.